BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24063618)

  • 1. Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero-screening.
    Ishihara K; Inokuchi N; Tsushima Y; Tsuruda K; Morinaga Y; Hasegawa H; Yanagihara K; Kamihira S
    J Immunoassay Immunochem; 2014; 35(1):74-82. PubMed ID: 24063618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
    Umeki K; Umekita K; Hashikura Y; Yamamoto I; Kubo K; Nagatomo Y; Okayama A
    Clin Lab; 2017 Feb; 63(2):227-233. PubMed ID: 28182361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The best algorithm to confirm the diagnosis of HTLV-1 and HTLV-2 in at-risk individuals from São Paulo, Brazil.
    Costa EA; Magri MC; Caterino-de-Araujo A
    J Virol Methods; 2011 May; 173(2):280-6. PubMed ID: 21349293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.
    Okuma K; Kuramitsu M; Niwa T; Taniguchi T; Masaki Y; Ueda G; Matsumoto C; Sobata R; Sagara Y; Nakamura H; Satake M; Miura K; Fuchi N; Masuzaki H; Okayama A; Umeki K; Yamano Y; Sato T; Iwanaga M; Uchimaru K; Nakashima M; Utsunomiya A; Kubota R; Ishitsuka K; Hasegawa H; Sasaki D; Koh KR; Taki M; Nosaka K; Ogata M; Naruse I; Kaneko N; Okajima S; Tezuka K; Ikebe E; Matsuoka S; Itabashi K; Saito S; Watanabe T; Hamaguchi I
    Retrovirology; 2020 Aug; 17(1):26. PubMed ID: 32831150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results.
    Waters A; Oliveira AL; Coughlan S; de Venecia C; Schor D; Leite AC; Araújo AQ; Hall WW
    J Clin Virol; 2011 Sep; 52(1):38-44. PubMed ID: 21704554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results.
    Vitone F; Gibellini D; Schiavone P; D'Antuono A; Gianni L; Bon I; Re MC
    BMC Infect Dis; 2006 Mar; 6():41. PubMed ID: 16512894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.
    Kuramitsu M; Sekizuka T; Yamochi T; Firouzi S; Sato T; Umeki K; Sasaki D; Hasegawa H; Kubota R; Sobata R; Matsumoto C; Kaneko N; Momose H; Araki K; Saito M; Nosaka K; Utsunomiya A; Koh KR; Ogata M; Uchimaru K; Iwanaga M; Sagara Y; Yamano Y; Okayama A; Miura K; Satake M; Saito S; Itabashi K; Yamaguchi K; Kuroda M; Watanabe T; Okuma K; Hamaguchi I
    J Clin Microbiol; 2017 Sep; 55(9):2838-2849. PubMed ID: 28701419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic challenges: lymphotropic sero-"questionables".
    Fox E; Constantine NT; Rodier G; Abbatte EA
    East Afr Med J; 1992 Oct; 69(10):563-5. PubMed ID: 1473510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil.
    da Silva Brito V; Santos FLN; Gonçalves NLS; Araujo THA; Nascimento DSV; Pereira FM; Boa-Sorte NCA; Grassi MFR; Caterino-de-Araujo A; Galvão-Castro B
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a real-time PCR assay for a novel HTLV-1 tax sequence detection and proviral load quantitation.
    Castro GM; Balangero MC; Maturano E; Mangeaud A; Gallego SV
    J Virol Methods; 2013 May; 189(2):383-7. PubMed ID: 23499262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions.
    Martins ML; Santos AC; Namen-Lopes MS; Barbosa-Stancioli EF; Utsch DG; Carneiro-Proietti AB
    J Med Virol; 2010 Oct; 82(10):1746-53. PubMed ID: 20827773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.
    Andrade RG; Ribeiro MA; Namen-Lopes MS; Silva SM; Basques FV; Ribas JG; Carneiro-Proietti AB; Martins ML
    Rev Soc Bras Med Trop; 2010; 43(2):111-5. PubMed ID: 20464136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
    Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction amplified HTLV-I, HIV-1 and HIV-2 DNA fragments in subjects with mixed retroviral infections.
    Kolesnitchenko V; Agius G; Zagury JF; Laaroubi K; Achour A; Castets M; Zagury D
    J Med Microbiol; 1993 May; 38(5):328-36. PubMed ID: 8387601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strip immunoblot for the confirmation of HTLV-I/II infection.
    Vrielink H; Zaaijer HL; Van der Poel CL; Quan S; Cuypers HT; Rios M; Lelie PN; Polito A; Sra K; DiNello R; Pichuantes S; Larson D; Reesink HW
    Vox Sang; 1996; 70(2):114-6. PubMed ID: 8801759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.